Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

about

Resistant mutations in CML and Ph(+)ALL - role of ponatinib.Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.

P2860

Q27853085-86808931-2BA1-4016-A6A9-A256D5456898 Q35602348-F83B3138-3DD2-49D5-AE0B-E2DC504B9982

P2860

Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

Item

http://www.wikidata.org/entity/Q36699009

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

@ast

Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

@en

type

Item

label

Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

@ast

Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

@en

prefLabel

Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

@ast

Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

@en

P1476

Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

@en

P2093

Jeffrey W Tyner

http://www.w3.org/2001/XMLSchema#string

Kim-Hien T Dao

http://www.w3.org/2001/XMLSchema#string

P2860

Hedgehog signaling is dispensable for adult hematopoietic stem cell function

Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia.

Activation of the Hedgehog pathway in chronic myelogeneous leukemia patients.

Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis.

Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance.

Novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells.

Intricacies of hedgehog signaling pathways: a perspective in tumorigenesis.

Selective elimination of leukemia stem cells: hitting a moving target.

Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status.

P304

1309-1311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-12-3934

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235402051

http://www.w3.org/2001/XMLSchema#string

P698

23382113

http://www.w3.org/2001/XMLSchema#string

P932

3602391

http://www.w3.org/2001/XMLSchema#string

Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

about

P2860

P2860

Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932